EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Symptoms, Treatment, and Outcomes of COVID-19 Patients Coinfected with Clostridioides difficile: Single-Center Study from NE Romania during the COVID-19 Pandemic

Lidia Oana Stămăteanu, Ionela Larisa Miftode iD, Claudia Elena Pleșca, Olivia Simona Dorneanu iD, Manuel Florin Roșu, Ioana Diandra Miftode, Maria Obreja, Egidia Gabriela Miftode

Antibiotics · 22.06.2023 · 12 (7) · 1091

DOI: 10.3390/antibiotics12071091 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antibiotics, online erschienen am 22.06.2023. Verfasst von Lidia Oana Stămăteanu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine II, Faculty of Medicine, University of Medicine and Pharmacy Gr. T. Popa, 700115 Iași, Romania. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Coronavirus disease 2019 (COVID-19) pandemic has brought new challenges across medical disciplines, particularly in infectious disease medicine. In Romania, the incidence of SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2) infection increased dramatically since March 2020 until March 2022. Antibiotic administration for pulmonary superinfections in COVID-19 intensified and, consequently, increased rates of Clostridioides difficile infection (CDI) were hypothesized. We conducted a single-center, retrospective, observational study on patients from North-Eastern Romania to assess clinical characteristics and outcomes of COVID-19 and Clostridioides difficile (CD) coinfection, and to identify risk factors for CDI in COVID-19 patients. The study enrolled eighty-six CDI and COVID-19 coinfected patients admitted during March 2020–February 2021 (mean age 59.14 years, 53.49% men, 67.44% urban residents) and a group of eighty-six COVID-19 patients. On admission, symptoms were more severe in mono-infected patients, while coinfected patients associated a more intense acute inflammatory syndrome. The main risk factors for severe COVID-19 were smoking, diabetes mellitus, and antibiotic administration. Third generation cephalosporins (55%) and carbapenems (24%) were the main antibiotics used, and carbapenems were significantly associated with severe COVID-19 in patients coinfected with CD during hospitalization. Coinfection resulted in longer hospitalization and poorer outcomes. The extensive use of antibiotics in COVID-19, particularly carbapenems, contributed substantially to CD coinfection.

Schlagwörter

Stichwörter der Autor:innen

Clostridioides difficile infectionSARS-CoV-2antibiotic stewardshipantimicrobial resistanceco-infections

Autor:innen und Institutionen

  • Department of Internal Medicine II, Faculty of Medicine, University of Medicine and Pharmacy Gr. T. Popa, 700115 Iași, Romania.
  • "St. Parascheva" Clinical Hospital of Infectious Diseases, 700116 Iași, Romania.
  • Department of Preventive Medicine and Interdisciplinarity, Faculty of Medicine, University of Medicine and Pharmacy Gr. T. Popa, 700115 Iași, Romania.
  • Department of Intensive Care Unit, Infectious Diseases Clinical Hospital, 700115 Iași, Romania.
  • Department of Radiology, "St. Spiridon" Emergency Clinical Hospital, 700111 Iași, Romania.

ORCID-Profile: Ionela Larisa Miftode, Olivia Simona Dorneanu

Zitieren

APA

Stămăteanu, L. O., Miftode, I. L., Pleșca, C. E., Dorneanu, O. S., Roșu, M. F., Miftode, I. D., Obreja, M., & Miftode, E. G. (2023). Symptoms, Treatment, and Outcomes of COVID-19 Patients Coinfected with Clostridioides difficile: Single-Center Study from NE Romania during the COVID-19 Pandemic. Antibiotics, 12(7), 1091. https://doi.org/10.3390/antibiotics12071091

Vancouver

Stămăteanu LO, Miftode IL, Pleșca CE, Dorneanu OS, Roșu MF, Miftode ID, et al. Symptoms, Treatment, and Outcomes of COVID-19 Patients Coinfected with Clostridioides difficile: Single-Center Study from NE Romania during the COVID-19 Pandemic. Antibiotics. 2023;12(7):1091. doi:10.3390/antibiotics12071091

BibTeX
@article{Stmteanu2023,
  author = {Stămăteanu, Lidia Oana and Miftode, Ionela Larisa and Pleșca, Claudia Elena and Dorneanu, Olivia Simona and Roșu, Manuel Florin and Miftode, Ioana Diandra and Obreja, Maria and Miftode, Egidia Gabriela},
  title = {Symptoms, Treatment, and Outcomes of COVID-19 Patients Coinfected with Clostridioides difficile: Single-Center Study from NE Romania during the COVID-19 Pandemic},
  journal = {Antibiotics},
  year = {2023},
  volume = {12},
  number = {7},
  pages = {1091},
  doi = {10.3390/antibiotics12071091}
}
Kostenlos starten →